Introduction
The hamster buccal pouch (HBP*) model of oral carcinogenesis has been used extensively for the study of premalignant processes (1) (2) (3) (4) (5) (6) (7) (8) , identification of putative intermediate markers of carcinoma development (1-10) and evaluation of potential cancer chemopreventive agents (11) (12) (13) (14) . This model recapitulates many of the features observed during oral carcinogenesis in man (15-17). For example, many of the structural alterations observed in carcinogen-treated hamster pouch mucosa, both grossly and at the light microscopic level, closely resemble
•Abbreviations: HBP, hamster buccal pouch; DMBA, 7,12-dimethylbenz [a] anthracene; MBN, W-methyl-jV-benzylnitrosamine; SSCP, single-strand conformation polymorphism; G3PDH, glyceraldehyde-3-phosphate dehydrogenase.
© Oxford University Press those observed during the course of human oral cancer development (15, 16, 18) . Some of the specific molecular changes which are likely to have mechanistic relevance to oral carcinoma development in man have also been identified and linked to temporal stages in carcinogenesis in this model. Biswas and colleagues have demonstrated that Ha-ras mutations occur in the very early pre-dysplastic phase of HBP carcinogenesis mediated by 7,12-dimethylbenz[a]anthracene (DMBA) and that late events include amplification and overexpression of c-erbB and its product, the epidermal growth factor receptor (19, 20) .
Alterations in the p53 tumor suppressor gene and its expression occur in a majority of head and neck carcinomas and their precursor lesions, including those of oral mucosa (21) (22) (23) (24) (25) . Cell hybridization studies have provided evidence that loss of suppressor gene function may also play a role in cancer development in the HBP model (7) . In addition, Conti and colleagues have recently obtained immunohistochemical evidence that endophytic DMBA-induced HBP carcinomas express an altered protein product resulting from mutation in the p53 tumor suppressor gene (26) . In view of these observations, the present study was undertaken to identify and characterize p53 and Ha-ras mutations occurring in the HBP model of oral carcinogenesis. The results demonstrate the occurrence of p53 and Ha-ras mutations in HBP carcinomas induced with two different chemical carcinogens.
Materials and methods

Animals and carcinogen treatment
Six male Syrian golden hamsters, 3-5 weeks of age, were treated by painting both buccal pouches each Monday and Friday for 15 weeks with a 1% solution of W-methyl-A'-benzylnitrosamine (MBN) dissolved in propylene glycol (18) . Six hamsters were similarly treated twice weekly with a 0.5% solution of DMBA in mineral oil (4) . Individual control hamsters were also treated in a similar manner with either solvent alone. Within 1 week after completing treatment the hamsters were sacrificed and gross tumors were excised and analyzed for the presence or mutations of p53 exons 5-8 and Ha-ras mutations at codons 12/13 and 61. A small section of each tumor was also fixed in formalin and processed for routine histological evaluation.
DM4 and RNA isolation Tumor DNA was isolated by conventional proteinase K/phenol/chloroform extraction (27) . Tumors of sufficient size were used to extract RNA to make a comparison of relative expression of the mdm-2 gene by Northern blot analysis using the RNAzol (Tel-Test Inc., Friendswood, TX) method (28) .
Polymerase chain reaction
Segments of the hamster p53 gene were amplified in vitro by PCR, as previously described (29) , using the following oligonucleoude primers:
A hamster Ha-ras sequence of 68 bp, including codons 12 and 13 of exon 1, was amplified using the synthetic oligonucleotide rat primers 5'-AAGCTTGTGGTGGTGGGCGC-3' and 3'-TAGGTCGACTAGGTCTTGGT-5' (30) . A hamster Ha-ras sequence of 175 bp, including codon 61 of exon 2, was amplified using the mouse primers 5'-GACTCCTACCGGAAACAGGT-3' and 3'-CTTCTGTAGGTAGTCATGTC-5' (20) . Parameters for amplification were 1 min at 94°C, I min at 55-57°C and 1 mm at 72°C for 35 cycles. All amplifications were performed in a Temp/Cycler II (Grass Lake, MI).
Single-stranded conformation polymorphism (SSCP) analvsis
A primary amplification was executed in duplicate as described above with unlabeled primers. The sense strand was analyzed in a second amplification in which the only sense oligonucleotide was end-labeled with [•^3
2 P]ATP (DuPont/New England Nuclear, Wilmington, DE) using T4 polynucleoude kinase (Promega, Madison, WI). The amplified product with only one strand radioactively tagged was added to a formamide-based loading buffer, denatured at 95°C for 5 min, cooled on ice for 10 min and loaded onto a 1 X MDE gel matrix (AT Biochem, Malvem, PA) with 1 X Tris-borate, EDTA buffer (29) Electrophoreses were at 20 W constant power with two fans used to maintain the gels at room temperature for 12-16 h until the xylene cyanol dye was >30 cm from the top of the gel. The gels were transferred to Whatman 3MM paper and vacuum dried at 70°C. Autoradiography was at -70°C for 2-5 h with one intensifying screen (Hyperscreen; Amersham, Arlington Heights, IL) and Hyperfilm-MP (Amersham) (29) .
Cloning and sequencing
Abnormally shifted bands revealed by SSCP were excised from each gel after alignment with the corresponding X-ray film (31) . The excised bands were incubated in 100 ml water at 95°C for 2 h and then at 37°C overnight. One tenth of the solution was used to repeat each amplification using the same PCR conditions. Each amplification was performed in duplicate and the two products were pooled for cloning. All PCR products then were cloned into the pGEM-T (Promega) vector. Sequencing was performed on mixed clones and/or purified re-amplified PCR products with the use of a fmol cycle sequencing kit (Promega) and pnmers end-labeled with |Y-32 P]ATP (Dupont/ New England Nuclear).
Northern analysis
Approximately 20 mg total RNA from 10 MBN-and five DMBA-induced tumors and controls were denatured in the presence of formamide, fractionated in a formaldehyde-containing 1% agarose gel and transferred to Zeta-probe membranes (BioRad). Membranes were incubated in prehybridization buffer for 2 h and then overnight in the same buffer containing 32 P-labeled mdm-2 and W/ndlll 186 bp glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA probes (28) Following hybridization the membranes were washed in a high stringency buffer. The membranes were exposed to X-ray film with an intensifying screen for 3 days prior to development. The intensity of signals was quantified by image analysis on a Fujix Bio-Imaging analyzer The tumor and control mdm-2 signals were compared after normalizing for each internal G3PDH signal. In addition, autoradiograms of Northern blots selected for presentation herein were scanned with a Hoefer Scientific Instruments GS 300 Transmittance/Reflectance Scanning Densitometer and the densities of the tumor mdm-2 and G3PDH bands were compared with the corresponding bands of control pouch tissue.
Results
Fourteen MBN-induced carcinomas and eight DMBA-induced carcinomas were obtained for evaluation by SSCP analysis and sequencing of their p53 and Ha-ras DNAs. Each of the tumors were well differentiated squamous cell carcinomas. No histological differences were observed between the carcinomas Table I . p53 induced
Ha-ras mutations were detected in three (21%) of the MBNinduced carcinomas and in three (37%) of the DMBA-induced carcinomas. The results are summarized in Table I .
Seven of the 14 MBN-induced tumors showed altered band migrations of p53 or Ha-ras DNA by SSCP analysis. An example of the SSCP results is shown in Figure la Figures Ib, 2b and 3 . The most common mutations observed (63%) were G-»A transitions. One tumor (tumor 14; Table I ) exhibited a protein-altering mutation in both p53 and Ha-ras. Of the five tumors exhibiting a p53 mutation, three (tumors 4, 9 and 14; Table I) Table I ). Table I ) and those without p53 mutations, shown in lanes 4 and 5 (tumors 4 and 9 in Table I ). The more prominent bands, for G3PDH (lower bands at 1. sion and mutation in HBP carcinogenesis mediated by DMBA (6, 20, 32) . Using the techniques of oligonucleotide mismatch hybridization Biswas and colleagues adduced evidence for Ha-ras codon 61 A-»T substitutions during the early stages of DMBA carcinogenesis (20) . Evidence for a role of Ha-ras mutations was also provided by Gimenez-Conti et al., who found A->T transversions in six of 11 (55%) DMBA-induced buccal pouch carcinomas (32) . The present study is the first to demonstrate Ha-ras mutations in /V-nitrosamine-induced buccal pouch carcinomas. Whereas DMBA appears to result in codon 61 A->T transversions in HBP and mouse skin (33) , in the present study two of the three Ha-ras mutations observed in the MBN-induced tumors were G-»A transitions in codon 12. This is also the predominant Ha-ras point mutation observed in MBN-induced esophageal papillomas of the rat (30, 31) . This is the first study to demonstrate and characterize specific mutations in the p53 gene in HBP carcinogenesis. The pattern of mutations observed mirrors those reported in a study of MBN-induced rat esophageal papillomas, wherein the frequency of p53 mutations was four of 11 (36%) in each of two strains of rats and G->A and C->T transitions accounted for 90% of the characterized p53 point mutations (31) . In the present study three of 14 (21%) MBN-induced carcinomas exhibited p53 protein-altering point mutations. The majority of MBN-induced mutations were G-»A transitions and it is intriguing to note that G-»A transitions are the most common p53 mutations occurring in human head and neck cancer, including those of oral mucosa (34) . It should also be noted that the two p53 protein-altering G-»A transitions observed in MBN-induced carcinomas (tumors 4 and 14; Table 1 ) occurred at hamster codon 248, which corresponds to human p53 codon 245 (35), a known high frequency mutational 'hot spot' for human tumors (34) .
It is well established that p53 dysfunction may also result from mechanisms other than mutation (36) . For example, p53 functions may be altered when the wild-type p53 protein binds to specific viral proteins or to endogenous mdm-2 protein, the product of a gene which is overexpressed in a variety of neoplasms (36) (37) (38) (39) . However, in the present study there was no evidence of mdm-2 overexpression in any of the buccal pouch carcinomas examined.
The present study describes specific genetic changes in chemically induced HBP carcinomas which have frequently been observed in human oral carcinomas. The spectrum of molecular alterations identified in oral carcinomas exhibit wide global variations, which appear to be largely a function of indigenous chewing habits, smoking habits and alcoholic beverage consumption (21, 22, 34, (40) (41) (42) (43) (44) (45) (46) . For example, Ha-ras mutations are observed in oral carcinomas induced by constituents of the betel quid popular in many Asian cultures (40) . These mutations are an infrequent occurrence among populations where smoking tobacco products and alcohol are the principal causes of oral cancer (41) (42) (43) (44) . Conversely, whereas the frequency of p53 mutations in oral carcinoma is high among patient populations in the West (21, 22, 34) , p53 mutations are infrequent in specific Eastern populations, where chewing of betel quid, with or without tobacco, is most strongly implicated (45, 46) . As the present study demonstrates, both Ha-ras and p53 mutations may arise during HBP carcinogenesis. The apparent overlap in the spectrum of molecular lesions observed in oral and HBP carcinomas should provide further support for the analytical value of this animal model. Several immunohistochemical studies have demonstrated p53 expression in pre-invasive oral lesions and thus it has been proposed that p53 mutation is a common early event in oral carcinogenesis (23) (24) (25) . Expression of wild-type p53 is up-regulated when DNA is damaged and this leads to a block in cell replication which enables DNA repair processes to proceed with fidelity (47) (48) (49) . In principle, loss of this normal p53 function is likely to confer a selective growth advantage on mutant p53 pre-cancerous cell populations in the oral mucosa and contribute to their genetic instability and malignant progression in response to repeated exposures to tobaccospecific jV-nitrosamines and other DNA damaging agents in tobacco products. Similar mechanisms are likely to foster clonal expansion of pre-cancerous lesions in the HBP model, wherein acute inhibition of cell replication results from carcinogen application (8, 50) . If p53 mutation is also a frequent early event in MBN-mediated HBP carcinogenesis, this model may prove valuable for a detailed analysis of the sequence of molecular events in carcinogen-exposed squamous mucosa beginning with early p53 mutant cell populations.
The HBP model has been used extensively for cancer chemoprevention studies, most notably in studies of retinoids and related compounds, which appear efficacious in retarding development of tobacco smoke-induced lesions in humans (11-14,51-53) . The future identification of very early (e.g. pre-invasive or pre-dysplastic) carcinogen-induced mutant p53 lesions in hamster pouch epithelium could also provide a valuable new approach for evaluating presumptive cancer chemopreventive agents for oral mucosa and contiguous head and neck sites. If MBN-induced p53 mutant populations arise early during HBP carcinogenesis, in a manner similar to their early occurrence in human oral mucosa, the identification of early focal mutant p53 populations in buccal pouch epithelium may serve as a rapid quantitative index of ongoing carcinogenesis. Predictably, prior and concurrent administration of effective oral anticarcinogenic agents would impede or prevent the induction, clonal expansion, dysplastic conversion or malignant progression of these early mutant p53 lesions. The utility of HBP epithelium for enumeration of early carcinogeninduced intra-epithelial pre-cancerous lesions (4, 18, 54) and their numerical reduction by concurrent administration of anticarcinogen has been previously demonstrated (14, 55) .
